HADM_ID,ICUSTAY_ID,CHARTTIME,CATEGORY,DESCRIPTION,TEXT,Summary
173304.0,283256,2160-12-25 06:38:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   STEMI
   24 Hour Events:
   8 hr post cath check unremarkable.
   Allergies:
   Sulfonamides
   Unknown;
   Other ICU medications:
   Heparin Sodium (Prophylaxis) - [**2160-12-24**] 10:00 PM
   Morphine Sulfate - [**2160-12-25**] 02:20 AM
   Other medications:
   Atorvastatin 80mg
   Heparin 5000u sc
   Colace 100mg [**Hospital1 7**]
   ASA 325 daily
   Plavix 75mg
   Prns:
   APAP
   Morphine Sulfate IV
   Senna
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2160-12-25**] 06:29 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.1
C (98.7
   Tcurrent: 36.6
C (97.9
   HR: 56 (51 - 63) bpm
   BP: 100/66(74) {88/58(62) - 109/75(81)} mmHg
   RR: 23 (11 - 24) insp/min
   SpO2: 97%
   Heart rhythm: SB (Sinus Bradycardia)
             Total In:
                                                                  1,284 mL
                                                                    405 mL
   PO:
                                                                    240 mL
             TF:
   IVF:
                                                                  1,044 mL
                                                                    405 mL
   Blood products:
   Total out:
                                                                    450 mL
                                                                    325 mL
   Urine:
                                                                    450 mL
                                                                    325 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    834 mL
                                                                     80 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 97%
   ABG: ////
   Physical Examination
   Gen: WDWN middle aged male in NAD. Oriented x3. Mood, affect
   appropriate.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   Neck: Supple with JVP of 8 cm.
   CV: PMI located in 5th intercostal space, midclavicular line. RR,
   normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4.
   Chest: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. CTAB, no crackles, wheezes or
   rhonchi.
   Abd: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by
   palpation. No abdominial bruits.
   Ext: No c/c/e. No femoral bruits on L. Femoral sheath in place on R
   Skin: No stasis dermatitis, ulcers, scars, or xanthomas.
   Labs / Radiology
   163 K/uL
   13.6 g/dL
   4.5 mEq/L
   106 mEq/L
   139 mEq/L
   37.9 %
   17.1 K/uL
        [image002.jpg]
                            [**2160-12-24**]  10:49 AM
                            [**2160-12-24**]  06:26 PM
                            [**2160-12-25**]  12:18 AM
   WBC
   17.1
   Hct
   37.9
   Plt
   [**Telephone/Fax (3) 3547**]
   TropT
   10.95
   8.17
   Other labs: CK / CKMB / Troponin-T:2900/204/8.17
   Assessment and Plan
   ASSESSMENT AND PLAN:  59 yo M with PMH of CAD s/p RCA stent in '[**48**]
   presenting with inferior STEMI, found to have in stent thrombosis and
   restenosis of prior RCA stent, now s/p stent to (prox) RCA.
   .
   #. CAD: EKG consistent with inferoposterolateral ischemia. Cardiac cath
   notable RCA disease s/p drug-eluting stent, 40% stenosis in LAD and LCX
   as well as a myocardial bridge.  Risk factors for CAD include
   borderline hypertension and dyslipidemia, both formerly diet
   controlled. Most recent lipid panel notable for LDL of 123.
   - Start high dose ASA, plavix, high dose statin
   - Start bblocker, ACE-I as blood pressure and HR tolerates
   - Follow CE's until peak
   - Ck HgA1C for risk reduction
   - 2hr platelet ck while on integrillin
   - Post cath ck this evening
   - Morphine PRN for CP
   .
   #. Pump: No history of CHF by history or symptoms. [**Month (only) 51**] have component
   of diastolic dysfunction given history of hypertension.
   - Evaluate with ECHO
   .
   #. Rhythm: Sinus bradycardia. Hold on bblocker for now.
   - Monitor on tele
   .
   #. Borderline HTN:
   - monitor BP's on cardiac meds
   .
   #. Hyperlipidemia:
   - start high dose statin
   .
   #. FEN: Cardiac diet. Follow and replete electrolytes.
   .
   #. Access: PIV
   .
   #. PPx: PO diet.
   .
   #. Code: Full
   .
   #. Contact: Girlfriend for 26 years, [**First Name8 (NamePattern2) 787**] [**Last Name (NamePattern1) 3548**]
               H: [**Telephone/Fax (1) 3549**]
               C: [**Telephone/Fax (1) 3550**]
   .
   #. Dispo: CCU for now; will likely call out to [**Hospital Ward Name 289**] 3 in AM
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   18 Gauge - [**2160-12-24**] 10:00 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   STEMI
   24 Hour Events:
   8 hr post cath check unremarkable.
   Allergies:
   Sulfonamides
   Unknown;
   Other ICU medications:
   Heparin Sodium (Prophylaxis) - [**2160-12-24**] 10:00 PM
   Morphine Sulfate - [**2160-12-25**] 02:20 AM
   Other medications:
   Atorvastatin 80mg
   Heparin 5000u sc
   Colace 100mg [**Hospital1 7**]
   ASA 325 daily
   Plavix 75mg
   Prns:
   APAP
   Morphine Sulfate IV
   Senna
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2160-12-25**] 06:29 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.1
C (98.7
   Tcurrent: 36.6
C (97.9
   HR: 56 (51 - 63) bpm
   BP: 100/66(74) {88/58(62) - 109/75(81)} mmHg
   RR: 23 (11 - 24) insp/min
   SpO2: 97%
   Heart rhythm: SB (Sinus Bradycardia)
             Total In:
                                                                  1,284 mL
                                                                    405 mL
   PO:
                                                                    240 mL
             TF:
   IVF:
                                                                  1,044 mL
                                                                    405 mL
   Blood products:
   Total out:
                                                                    450 mL
                                                                    325 mL
   Urine:
                                                                    450 mL
                                                                    325 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    834 mL
                                                                     80 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 97%
   ABG: ////
   Physical Examination
   Gen: WDWN middle aged male in NAD. Oriented x3. Mood, affect
   appropriate.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   Neck: Supple with JVP of 8 cm.
   CV: PMI located in 5th intercostal space, midclavicular line. RR,
   normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4.
   Chest: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. CTAB, no crackles, wheezes or
   rhonchi.
   Abd: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by
   palpation. No abdominial bruits.
   Ext: No c/c/e. No femoral bruits on L. Femoral sheath in place on R
   Skin: No stasis dermatitis, ulcers, scars, or xanthomas.
   Labs / Radiology
   163 K/uL
   13.6 g/dL
   4.5 mEq/L
   106 mEq/L
   139 mEq/L
   37.9 %
   17.1 K/uL
        [image002.jpg]
                            [**2160-12-24**]  10:49 AM
                            [**2160-12-24**]  06:26 PM
                            [**2160-12-25**]  12:18 AM
   WBC
   17.1
   Hct
   37.9
   Plt
   [**Telephone/Fax (3) 3547**]
   TropT
   10.95
   8.17
   Other labs: CK / CKMB / Troponin-T:2900/204/8.17
   Assessment and Plan
   ASSESSMENT AND PLAN:  59 yo M with PMH of CAD s/p RCA stent in '[**48**]
   presenting with inferior STEMI, found to have in stent thrombosis and
   restenosis of prior RCA stent, now s/p stent to (prox) RCA.
   .
   #. CAD: EKG consistent with inferoposterolateral ischemia. Cardiac cath
   notable RCA disease s/p drug-eluting stent, 40% stenosis in LAD and LCX
   as well as a myocardial bridge.  Risk factors for CAD include
   borderline hypertension and dyslipidemia, both formerly diet
   controlled. Most recent lipid panel notable for LDL of 123.
   - Start high dose ASA, plavix, high dose statin
   - Start bblocker, ACE-I as blood pressure and HR tolerates
   - Follow CE's until peak
   - Ck HgA1C for risk reduction
   - 2hr platelet ck while on integrillin
   - Post cath ck this evening
   - Morphine PRN for CP
   .
   #. Pump: No history of CHF by history or symptoms. [**Month (only) 51**] have component
   of diastolic dysfunction given history of hypertension.
   - Evaluate with ECHO
   .
   #. Rhythm: Sinus bradycardia. Hold on bblocker for now.
   - Monitor on tele
   .
   #. Borderline HTN:
   - monitor BP's on cardiac meds
   .
   #. Hyperlipidemia:
   - start high dose statin
   .
   #. FEN: Cardiac diet. Follow and replete electrolytes.
   .
   #. Access: PIV
   .
   #. PPx: PO diet.
   .
   #. Code: Full
   .
   #. Contact: Girlfriend for 26 years, [**First Name8 (NamePattern2) 787**] [**Last Name (NamePattern1) 3548**]
               H: [**Telephone/Fax (1) 3549**]
               C: [**Telephone/Fax (1) 3550**]
   .
   #. Dispo: CCU for now; will likely call out to [**Hospital Ward Name 289**] 3 in AM
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   18 Gauge - [**2160-12-24**] 10:00 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 59-year-old male who presented with an inferior STEMI, found to have in-stent thrombosis and restenosis of a prior RCA stent. He underwent stenting of the proximal RCA and is currently in the ICU. His vital signs are stable, with a heart rate of 56 bpm, blood pressure of 100/66 mmHg, and oxygen saturation of 97%. He has a history of CAD, hypertension, and dyslipidemia.

Physical examination reveals a well-appearing patient with a normal heart rate and rhythm. His chest is clear, and his abdomen is soft and non-tender. He has no signs of heart failure or peripheral edema.

Laboratory results show elevated troponin levels, with a peak level of 8.17 ng/mL. His WBC count is 17.1 K/uL, and his platelet count is 163 K/uL.

Potential medical complications:

1. Cardiac complications: The patient's history of CAD and recent STEMI increase his risk of cardiac complications, such as heart failure, ventricular arrhythmias, and cardiac arrest.
2. Thrombotic complications: The patient's in-stent thrombosis and restenosis of the RCA stent increase his risk of thrombotic complications, such as myocardial infarction and stroke.
3. Bleeding complications: The patient's use of anticoagulant medications, such as heparin and clopidogrel, increases his risk of bleeding complications, such as gastrointestinal bleeding and hematuria.
4. Infection complications: The patient's use of central venous catheters and indwelling urinary catheters increases his risk of infection complications, such as sepsis and urinary tract infections.
5. Respiratory complications: The patient's history of CAD and recent STEMI increase his risk of respiratory complications, such as pneumonia and respiratory failure.

Assessment and plan:

The patient's assessment and plan include:

1. Cardiac catheterization to evaluate the extent of coronary artery disease and to perform percutaneous coronary intervention (PCI) if necessary.
2. Administration of anticoagulant medications, such as heparin and clopidogrel, to prevent thrombotic complications.
3. Administration of beta-blockers and ACE inhibitors to control blood pressure and heart rate.
4. Monitoring of the patient's cardiac rhythm and blood pressure to detect any changes or complications.
5. Monitoring of the patient's respiratory status and oxygen saturation to detect any changes or complications.
6. Evaluation of the patient's nutritional status and glycemic control to detect any changes or complications.
7. Monitoring of the patient's electrolyte levels and kidney function to detect any changes or complications.
8. Evaluation of the patient's mental status and cognitive function to detect any changes or complications."
173304.0,283256,2160-12-25 06:38:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   STEMI
   24 Hour Events:
   8 hr post cath check unremarkable.  Patient c/o mild CP o/n, resolved
   with Morphine, no EKG changes.
   Allergies:
   Sulfonamides
   Unknown;
   Other ICU medications:
   Heparin Sodium (Prophylaxis) - [**2160-12-24**] 10:00 PM
   Morphine Sulfate - [**2160-12-25**] 02:20 AM
   Other medications:
   Atorvastatin 80mg
   Heparin 5000u sc
   Colace 100mg [**Hospital1 7**]
   ASA 325 daily
   Plavix 75mg
   Prns:
   APAP
   Morphine Sulfate IV
   Senna
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2160-12-25**] 06:29 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.1
C (98.7
   Tcurrent: 36.6
C (97.9
   HR: 56 (51 - 63) bpm
   BP: 100/66(74) {88/58(62) - 109/75(81)} mmHg
   RR: 23 (11 - 24) insp/min
   SpO2: 97%
   Heart rhythm: SB (Sinus Bradycardia)
             Total In:
                                                                  1,284 mL
                                                                    405 mL
   PO:
                                                                    240 mL
             TF:
   IVF:
                                                                  1,044 mL
                                                                    405 mL
   Blood products:
   Total out:
                                                                    450 mL
                                                                    325 mL
   Urine:
                                                                    450 mL
                                                                    325 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    834 mL
                                                                     80 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 97%
   ABG: ////
   Physical Examination
   Gen: WDWN middle aged male in NAD. Oriented x3. Mood, affect
   appropriate.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   Neck: Supple with JVP of 8 cm.
   CV: PMI located in 5th intercostal space, midclavicular line. RR,
   normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4.
   Chest: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. CTAB, no crackles, wheezes or
   rhonchi.
   Abd: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by
   palpation. No abdominial bruits.
   Ext: No c/c/e. No femoral bruits on L. Femoral sheath in place on R
   Skin: No stasis dermatitis, ulcers, scars, or xanthomas.
   Labs / Radiology
   137
                               [image002.gif]
                                     103
                               [image002.gif]
                                     15
   [image004.gif]
   106
                                                                   AGap=15
   [image005.gif]
   5.0
                               [image002.gif]
                                     24
                               [image002.gif]
                                     0.9
   [image007.gif]
   CK: 2195
   MB: 128
   MBI: 5.8
   Trop-T: 6.80
   Ca: 8.4 Mg: 2.1 P: 2.5
   89
                                                                      16.8
                                                            [image007.gif]
                                    13.3
   [image004.gif]
   156
                 [image008.gif]
   [image004.gif]
                                    36.7
   [image007.gif]
   PT: 12.3
   PTT: 26.5
   INR: 1.0
                            [**2160-12-24**]  10:49 AM
                            [**2160-12-24**]  06:26 PM
                            [**2160-12-25**]  12:18 AM
   WBC
   17.1
   Hct
   37.9
   Plt
   [**Telephone/Fax (3) 3547**]
   TropT
   10.95
   8.17
   Assessment and Plan
   ASSESSMENT AND PLAN:  59 yo M with PMH of CAD s/p RCA stent in '[**48**]
   presenting with inferior STEMI, found to have in stent thrombosis and
   restenosis of prior RCA stent, now s/p stent to (prox) RCA.
   .
   #. CAD: EKG consistent with inferoposterolateral ischemia.  AM EKG with
   persistent ST elevations and Q waves in II, III, AVF, Cardiac cath
   notable RCA disease s/p drug-eluting stent, 40% stenosis in LAD and LCX
   as well as a myocardial bridge.  Risk factors for CAD include
   borderline hypertension and dyslipidemia, both formerly diet
   controlled. Most recent lipid panel notable for LDL of 123.  Patient
   HR and BPs have been improving.
   - Continue ASA, plavix, high dose statin
   - Start Lisinopril 2.5mg, add BB if pressures tolerate
   - Morphine PRN for CP
   .
   #. Pump:  Patient with elevated JVP, c/w presentation.  Echo shows
   40-45% EF.
   .
   #. Rhythm: Sinus bradycardia. Hold on bblocker for now.
   - Monitor on tele
   .
   #. Hyperlipidemia:
   - start high dose statin
   .
   #. FEN: Cardiac diet. Follow and replete electrolytes.
   .
   #. Access: PIV
   .
   #. PPx: PO diet.
   .
   #. Code: Full
   .
   #. Contact: Girlfriend for 26 years, [**First Name8 (NamePattern2) 787**] [**Last Name (NamePattern1) 3548**]
               H: [**Telephone/Fax (1) 3549**]
               C: [**Telephone/Fax (1) 3550**]
   .
   #. Dispo: CCU for now; will likely call out to [**Hospital Ward Name 289**] 3 if pt stable.
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   18 Gauge - [**2160-12-24**] 10:00 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   STEMI
   24 Hour Events:
   8 hr post cath check unremarkable.  Patient c/o mild CP o/n, resolved
   with Morphine, no EKG changes.
   Allergies:
   Sulfonamides
   Unknown;
   Other ICU medications:
   Heparin Sodium (Prophylaxis) - [**2160-12-24**] 10:00 PM
   Morphine Sulfate - [**2160-12-25**] 02:20 AM
   Other medications:
   Atorvastatin 80mg
   Heparin 5000u sc
   Colace 100mg [**Hospital1 7**]
   ASA 325 daily
   Plavix 75mg
   Prns:
   APAP
   Morphine Sulfate IV
   Senna
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2160-12-25**] 06:29 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.1
C (98.7
   Tcurrent: 36.6
C (97.9
   HR: 56 (51 - 63) bpm
   BP: 100/66(74) {88/58(62) - 109/75(81)} mmHg
   RR: 23 (11 - 24) insp/min
   SpO2: 97%
   Heart rhythm: SB (Sinus Bradycardia)
             Total In:
                                                                  1,284 mL
                                                                    405 mL
   PO:
                                                                    240 mL
             TF:
   IVF:
                                                                  1,044 mL
                                                                    405 mL
   Blood products:
   Total out:
                                                                    450 mL
                                                                    325 mL
   Urine:
                                                                    450 mL
                                                                    325 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    834 mL
                                                                     80 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 97%
   ABG: ////
   Physical Examination
   Gen: WDWN middle aged male in NAD. Oriented x3. Mood, affect
   appropriate.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   Neck: Supple with JVP of 8 cm.
   CV: PMI located in 5th intercostal space, midclavicular line. RR,
   normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4.
   Chest: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. CTAB, no crackles, wheezes or
   rhonchi.
   Abd: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by
   palpation. No abdominial bruits.
   Ext: No c/c/e. No femoral bruits on L. Femoral sheath in place on R
   Skin: No stasis dermatitis, ulcers, scars, or xanthomas.
   Labs / Radiology
   137
                               [image002.gif]
                                     103
                               [image002.gif]
                                     15
   [image004.gif]
   106
                                                                   AGap=15
   [image005.gif]
   5.0
                               [image002.gif]
                                     24
                               [image002.gif]
                                     0.9
   [image007.gif]
   CK: 2195
   MB: 128
   MBI: 5.8
   Trop-T: 6.80
   Ca: 8.4 Mg: 2.1 P: 2.5
   89
                                                                      16.8
                                                            [image007.gif]
                                    13.3
   [image004.gif]
   156
                 [image008.gif]
   [image004.gif]
                                    36.7
   [image007.gif]
   PT: 12.3
   PTT: 26.5
   INR: 1.0
                            [**2160-12-24**]  10:49 AM
                            [**2160-12-24**]  06:26 PM
                            [**2160-12-25**]  12:18 AM
   WBC
   17.1
   Hct
   37.9
   Plt
   [**Telephone/Fax (3) 3547**]
   TropT
   10.95
   8.17
   Assessment and Plan
   ASSESSMENT AND PLAN:  59 yo M with PMH of CAD s/p RCA stent in '[**48**]
   presenting with inferior STEMI, found to have in stent thrombosis and
   restenosis of prior RCA stent, now s/p stent to (prox) RCA.
   .
   #. CAD: EKG consistent with inferoposterolateral ischemia.  AM EKG with
   persistent ST elevations and Q waves in II, III, AVF, Cardiac cath
   notable RCA disease s/p drug-eluting stent, 40% stenosis in LAD and LCX
   as well as a myocardial bridge.  Risk factors for CAD include
   borderline hypertension and dyslipidemia, both formerly diet
   controlled. Most recent lipid panel notable for LDL of 123.  Patient
   HR and BPs have been improving.
   - Continue ASA, plavix, high dose statin
   - Start Lisinopril 2.5mg, add BB if pressures tolerate
   - Morphine PRN for CP
   .
   #. Pump:  Patient with elevated JVP, c/w presentation.  Echo shows
   40-45% EF.
   .
   #. Rhythm: Sinus bradycardia. Hold on bblocker for now.
   - Monitor on tele
   .
   #. Hyperlipidemia:
   - start high dose statin
   .
   #. FEN: Cardiac diet. Follow and replete electrolytes.
   .
   #. Access: PIV
   .
   #. PPx: PO diet.
   .
   #. Code: Full
   .
   #. Contact: Girlfriend for 26 years, [**First Name8 (NamePattern2) 787**] [**Last Name (NamePattern1) 3548**]
               H: [**Telephone/Fax (1) 3549**]
               C: [**Telephone/Fax (1) 3550**]
   .
   #. Dispo: CCU for now; will likely call out to [**Hospital Ward Name 289**] 3 if pt stable.
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   18 Gauge - [**2160-12-24**] 10:00 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 59-year-old male who presented with an inferior STEMI, which was found to be due to in-stent thrombosis and restenosis of his prior RCA stent. He has undergone stenting of the proximal RCA.

The patient's current vital signs are:

* Temperature: 36.6°C (97.9°F)
* Heart rate: 56 beats per minute (bpm)
* Blood pressure: 100/66 mmHg
* Respiratory rate: 23 inspirations per minute
* Oxygen saturation: 97%

The patient's physical examination is unremarkable, with the exception of a supple neck with a jugular venous pressure (JVP) of 8 cm.

Laboratory results show:

* Troponin-T: 6.80 ng/mL
* Creatine kinase (CK): 2195 IU/L
* Cardiac enzymes: 15 ng/mL
* White blood cell count: 17.1 x 10^9/L
* Hematocrit: 37.9%
* Platelet count: 5.0 x 10^10/L

The patient's cardiac enzymes are elevated, indicating ongoing myocardial damage. His troponin-T level is elevated, consistent with myocardial infarction.

Potential medical complications that can arise include:

1. Cardiac arrhythmias: Given the patient's history of CAD and the presence of ST elevations on his EKG, he is at risk for cardiac arrhythmias, such as ventricular tachycardia or fibrillation.
2. Heart failure: The patient's reduced left ventricular ejection fraction (EF) of 40-45% increases his risk of developing heart failure.
3. Thrombotic complications: The patient's history of in-stent thrombosis and restenosis of his prior RCA stent increases his risk of developing thrombotic complications, such as deep vein thrombosis (DVT) or pulmonary embolism (PE).
4. Infection: The patient's presence in the ICU increases his risk of developing infection, particularly ventilator-associated pneumonia (VAP).
5. Hypotension: The patient's blood pressure is relatively low, which may indicate hypotension, particularly if his cardiac output is compromised.
6. Respiratory failure: The patient's respiratory rate is elevated, which may indicate respiratory failure or distress.
7. Gastrointestinal bleeding: The patient's use of anticoagulation therapy and his history of CAD increase his risk of gastrointestinal bleeding.

Based on the patient's condition, it is recommended that he continue to receive anticoagulation therapy, and that his cardiac medications be adjusted as necessary to optimize his cardiac function. Close monitoring of his cardiac enzymes and troponin-T levels will be necessary to assess the effectiveness of his treatment and to detect any potential complications."
173304.0,283256,2160-12-26 06:42:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 EKG - At [**2160-12-25**] 08:00 AM
   Allergies:
   Sulfonamides
   Unknown;
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Morphine Sulfate - [**2160-12-25**] 09:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2160-12-26**] 06:35 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.3
C (100.9
   Tcurrent: 37.4
C (99.3
   HR: 70 (60 - 77) bpm
   BP: 106/70(79) {93/53(62) - 110/73(80)} mmHg
   RR: 22 (16 - 28) insp/min
   SpO2: 93%
   Heart rhythm: SR (Sinus Rhythm)
                  Total In:
                                                                  1,045 mL
                  PO:
                                                                    640 mL
                  TF:
   IVF:
                                                                    405 mL
   Blood products:
   Total out:
                                                                  1,375 mL
                                                                    550 mL
   Urine:
                                                                  1,375 mL
                                                                    350 mL
   NG:
   Stool:
   200 mL
   Drains:
   Balance:
                                                                   -330 mL
                                                                   -550 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 93%
   ABG: ///24/
   Physical Examination
   Gen: WDWN middle aged male in NAD. Oriented x3. Mood, affect
   appropriate.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   Neck: Supple with JVP of 8 cm.
   CV: PMI located in 5th intercostal space, midclavicular line. RR,
   normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4.
   Chest: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. CTAB, no crackles, wheezes or
   rhonchi.
   Abd: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by
   palpation. No abdominial bruits.
   Ext: No c/c/e. No femoral bruits on L. Femoral sheath in place on R
   Skin: No stasis dermatitis, ulcers, scars, or xanthomas.
   Labs / Radiology
   180 K/uL
   14.6 g/dL
   97 mg/dL
   1.1 mg/dL
   24 mEq/L
   4.1 mEq/L
   20 mg/dL
   107 mEq/L
   142 mEq/L
   41.6 %
   17.5 K/uL
        [image002.jpg]
                            [**2160-12-24**]  10:49 AM
                            [**2160-12-24**]  06:26 PM
                            [**2160-12-25**]  12:18 AM
                            [**2160-12-25**]  06:25 AM
                            [**2160-12-26**]  05:12 AM
   WBC
   17.1
   16.8
   17.5
   Hct
   37.9
   36.7
   41.6
   Plt
   [**Telephone/Fax (3) 3586**]56
   180
   Cr
   0.9
   1.1
   TropT
   10.95
   8.17
   6.80
   Glucose
   106
   97
   Other labs: PT / PTT / INR:12.8/27.2/1.1, CK / CKMB /
   Troponin-T:2195/128/6.80, Ca++:8.4 mg/dL, Mg++:2.1 mg/dL, PO4:2.5 mg/dL
   Assessment and Plan
   ASSESSMENT AND PLAN:  59 yo M with PMH of CAD s/p RCA stent in '[**48**]
   presenting with inferior STEMI, found to have in stent thrombosis and
   restenosis of prior RCA stent, now s/p stent to (prox) RCA.
   .
   #. CAD: EKG consistent with inferoposterolateral ischemia.  AM EKG with
   persistent ST elevations and Q waves in II, III, AVF, Cardiac cath
   notable RCA disease s/p drug-eluting stent, 40% stenosis in LAD and LCX
   as well as a myocardial bridge.  Risk factors for CAD include
   borderline hypertension and dyslipidemia, both formerly diet
   controlled. Most recent lipid panel notable for LDL of 123.  Patient
   HR and BPs have been improving.
   - Continue ASA, plavix, high dose statin.
   - start low dose metoprolol, switch captopril to lisinopril
   .
   #. Pump:  Patient with elevated JVP, c/w RV failure presentation.  Echo
   shows 40-45% EF.
   .
   #. Rhythm: NSR with HR on low side.
   - Monitor on tele
   .
   #. Hyperlipidemia:
   - start high dose statin
   .
   #. FEN: Cardiac diet. Follow and replete electrolytes.
   .
   #. Access: PIV
   .
   #. PPx: PO diet.  SC Heparin
   .
   #. Code: Full
   .
   #. Contact: Girlfriend for 26 years, [**First Name8 (NamePattern2) 787**] [**Last Name (NamePattern1) 3548**]
               H: [**Telephone/Fax (1) 3549**]
               C: [**Telephone/Fax (1) 3550**]
   .
   #. Dispo: Call out today.
   1. IV access: Peripheral line, Date inserted: [**2160-12-24**] Order date:
   [**12-24**] @ 1019
   8. Heparin 5000 UNIT SC TID  Order date: [**12-24**] @ 1019
   2. Acetaminophen 325-650 mg PO Q6H:PRN  Order date: [**12-24**] @ 1019
   9. Influenza Virus Vaccine 0.5 mL IM ASDIR
   Follow Influenza Protocol Document administration in POE   Order date:
   [**12-24**] @ 1013
   3. Aspirin EC 325 mg PO DAILY  Order date: [**12-24**] @ 0934
   10. Morphine Sulfate 1-2 mg IV Q4H:PRN Pain
   Please hold for sedation or RR < 12.  Order date: [**12-24**] @ 1712
   4. Atorvastatin 80 mg PO DAILY  Order date: [**12-24**] @ 1019
   11. Senna 1 TAB PO BID:PRN  Order date: [**12-24**] @ 1019
   5. Captopril 3.125 mg PO TID
   Hold for SBP < 90  Order date: [**12-25**] @ 1326
   12. Sertraline 75 mg PO DAILY  Order date: [**12-25**] @ 1549
   6. Clopidogrel 75 mg PO DAILY
   for the recommended duration  Order date: [**12-24**] @ 0934
   13. Sodium Chloride 0.9% Flush 3 mL IV Q8H:PRN line flush
   Peripheral line: Flush with 3 mL Normal Saline every 8 hours and PRN.
   Order date: [**12-24**] @ 1019
   7. Docusate Sodium 100 mg PO BID  Order date: [**12-24**] @ 1019
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 EKG - At [**2160-12-25**] 08:00 AM
   Allergies:
   Sulfonamides
   Unknown;
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Morphine Sulfate - [**2160-12-25**] 09:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2160-12-26**] 06:35 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.3
C (100.9
   Tcurrent: 37.4
C (99.3
   HR: 70 (60 - 77) bpm
   BP: 106/70(79) {93/53(62) - 110/73(80)} mmHg
   RR: 22 (16 - 28) insp/min
   SpO2: 93%
   Heart rhythm: SR (Sinus Rhythm)
                  Total In:
                                                                  1,045 mL
                  PO:
                                                                    640 mL
                  TF:
   IVF:
                                                                    405 mL
   Blood products:
   Total out:
                                                                  1,375 mL
                                                                    550 mL
   Urine:
                                                                  1,375 mL
                                                                    350 mL
   NG:
   Stool:
   200 mL
   Drains:
   Balance:
                                                                   -330 mL
                                                                   -550 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 93%
   ABG: ///24/
   Physical Examination
   Gen: WDWN middle aged male in NAD. Oriented x3. Mood, affect
   appropriate.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   Neck: Supple with JVP of 8 cm.
   CV: PMI located in 5th intercostal space, midclavicular line. RR,
   normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4.
   Chest: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. CTAB, no crackles, wheezes or
   rhonchi.
   Abd: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by
   palpation. No abdominial bruits.
   Ext: No c/c/e. No femoral bruits on L. Femoral sheath in place on R
   Skin: No stasis dermatitis, ulcers, scars, or xanthomas.
   Labs / Radiology
   180 K/uL
   14.6 g/dL
   97 mg/dL
   1.1 mg/dL
   24 mEq/L
   4.1 mEq/L
   20 mg/dL
   107 mEq/L
   142 mEq/L
   41.6 %
   17.5 K/uL
        [image002.jpg]
                            [**2160-12-24**]  10:49 AM
                            [**2160-12-24**]  06:26 PM
                            [**2160-12-25**]  12:18 AM
                            [**2160-12-25**]  06:25 AM
                            [**2160-12-26**]  05:12 AM
   WBC
   17.1
   16.8
   17.5
   Hct
   37.9
   36.7
   41.6
   Plt
   [**Telephone/Fax (3) 3586**]56
   180
   Cr
   0.9
   1.1
   TropT
   10.95
   8.17
   6.80
   Glucose
   106
   97
   Other labs: PT / PTT / INR:12.8/27.2/1.1, CK / CKMB /
   Troponin-T:2195/128/6.80, Ca++:8.4 mg/dL, Mg++:2.1 mg/dL, PO4:2.5 mg/dL
   Assessment and Plan
   ASSESSMENT AND PLAN:  59 yo M with PMH of CAD s/p RCA stent in '[**48**]
   presenting with inferior STEMI, found to have in stent thrombosis and
   restenosis of prior RCA stent, now s/p stent to (prox) RCA.
   .
   #. CAD: EKG consistent with inferoposterolateral ischemia.  AM EKG with
   persistent ST elevations and Q waves in II, III, AVF, Cardiac cath
   notable RCA disease s/p drug-eluting stent, 40% stenosis in LAD and LCX
   as well as a myocardial bridge.  Risk factors for CAD include
   borderline hypertension and dyslipidemia, both formerly diet
   controlled. Most recent lipid panel notable for LDL of 123.  Patient
   HR and BPs have been improving.
   - Continue ASA, plavix, high dose statin.
   - start low dose metoprolol, switch captopril to lisinopril
   .
   #. Pump:  Patient with elevated JVP, c/w RV failure presentation.  Echo
   shows 40-45% EF.
   .
   #. Rhythm: NSR with HR on low side.
   - Monitor on tele
   .
   #. Hyperlipidemia:
   - start high dose statin
   .
   #. FEN: Cardiac diet. Follow and replete electrolytes.
   .
   #. Access: PIV
   .
   #. PPx: PO diet.  SC Heparin
   .
   #. Code: Full
   .
   #. Contact: Girlfriend for 26 years, [**First Name8 (NamePattern2) 787**] [**Last Name (NamePattern1) 3548**]
               H: [**Telephone/Fax (1) 3549**]
               C: [**Telephone/Fax (1) 3550**]
   .
   #. Dispo: Call out today.
   1. IV access: Peripheral line, Date inserted: [**2160-12-24**] Order date:
   [**12-24**] @ 1019
   8. Heparin 5000 UNIT SC TID  Order date: [**12-24**] @ 1019
   2. Acetaminophen 325-650 mg PO Q6H:PRN  Order date: [**12-24**] @ 1019
   9. Influenza Virus Vaccine 0.5 mL IM ASDIR
   Follow Influenza Protocol Document administration in POE   Order date:
   [**12-24**] @ 1013
   3. Aspirin EC 325 mg PO DAILY  Order date: [**12-24**] @ 0934
   10. Morphine Sulfate 1-2 mg IV Q4H:PRN Pain
   Please hold for sedation or RR < 12.  Order date: [**12-24**] @ 1712
   4. Atorvastatin 80 mg PO DAILY  Order date: [**12-24**] @ 1019
   11. Senna 1 TAB PO BID:PRN  Order date: [**12-24**] @ 1019
   5. Captopril 3.125 mg PO TID
   Hold for SBP < 90  Order date: [**12-25**] @ 1326
   12. Sertraline 75 mg PO DAILY  Order date: [**12-25**] @ 1549
   6. Clopidogrel 75 mg PO DAILY
   for the recommended duration  Order date: [**12-24**] @ 0934
   13. Sodium Chloride 0.9% Flush 3 mL IV Q8H:PRN line flush
   Peripheral line: Flush with 3 mL Normal Saline every 8 hours and PRN.
   Order date: [**12-24**] @ 1019
   7. Docusate Sodium 100 mg PO BID  Order date: [**12-24**] @ 1019<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, I summarize the patient's health status as follows:

The patient is a 59-year-old male with a history of coronary artery disease (CAD) who presented with an inferior ST-segment elevation myocardial infarction (STEMI) and was found to have in-stent thrombosis and restenosis of his prior RCA stent. He was admitted to the ICU and underwent a stent procedure to the proximal RCA. The patient's vital signs are stable, with a temperature of 37.4°C, heart rate of 70 beats per minute, and blood pressure of 106/70 mmHg. His respiratory rate is 22 breaths per minute, and his oxygen saturation is 93%.

The patient's physical examination reveals a well-nourished middle-aged male in no acute distress. His heart sounds are normal, and he has no murmurs, gallops, or thrills. His chest is clear, and his abdomen is soft and non-tender. His extremities are without edema or cyanosis.

Laboratory results show elevated troponin levels, consistent with myocardial infarction. His kidney function is normal, and his liver function tests are within normal limits. His white blood cell count is elevated, but his hemoglobin and platelet counts are normal.

The patient is receiving various medications, including aspirin, clopidogrel, atorvastatin, metoprolol, lisinopril, and morphine, among others. He is also receiving IV fluids and has a peripheral line for medication administration.

Potential medical complications that may arise from the patient's condition include:

1. Cardiac complications: The patient's history of CAD and recent STEMI puts him at risk for cardiac complications such as heart failure, arrhythmias, and cardiac arrest.
2. Respiratory complications: The patient's history of CAD and recent STEMI may increase his risk for respiratory complications such as pneumonia or acute respiratory distress syndrome.
3. Renal complications: The patient's history of CAD and recent STEMI may increase his risk for renal complications such as acute kidney injury or chronic kidney disease.
4. Bleeding complications: The patient's use of anticoagulant medications and recent stent procedure puts him at risk for bleeding complications such as gastrointestinal bleeding or intracranial hemorrhage.
5. Infection complications: The patient's history of CAD and recent STEMI may increase his risk for infection complications such as sepsis or endocarditis.
6. Neurological complications: The patient's history of CAD and recent STEMI may increase his risk for neurological complications such as stroke or transient ischemic attack.

Overall, the patient requires close monitoring and management to prevent and treat potential complications."
173304.0,283256,2160-12-26 06:42:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 EKG - At [**2160-12-25**] 08:00 AM
   Allergies:
   Sulfonamides
   Unknown;
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Morphine Sulfate - [**2160-12-25**] 09:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2160-12-26**] 06:35 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.3
C (100.9
   Tcurrent: 37.4
C (99.3
   HR: 70 (60 - 77) bpm
   BP: 106/70(79) {93/53(62) - 110/73(80)} mmHg
   RR: 22 (16 - 28) insp/min
   SpO2: 93%
   Heart rhythm: SR (Sinus Rhythm)
                  Total In:
                                                                  1,045 mL
                  PO:
                                                                    640 mL
                  TF:
   IVF:
                                                                    405 mL
   Blood products:
   Total out:
                                                                  1,375 mL
                                                                    550 mL
   Urine:
                                                                  1,375 mL
                                                                    350 mL
   NG:
   Stool:
   200 mL
   Drains:
   Balance:
                                                                   -330 mL
                                                                   -550 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 93%
   ABG: ///24/
   Physical Examination
   Gen: WDWN middle aged male in NAD. Oriented x3. Mood, affect
   appropriate.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   Neck: Supple with JVP of 8 cm.
   CV: PMI located in 5th intercostal space, midclavicular line. RR,
   normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4.
   Chest: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. CTAB, no crackles, wheezes or
   rhonchi.
   Abd: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by
   palpation. No abdominial bruits.
   Ext: No c/c/e. No femoral bruits on L. Femoral sheath in place on R
   Skin: No stasis dermatitis, ulcers, scars, or xanthomas.
   Labs / Radiology
   180 K/uL
   14.6 g/dL
   97 mg/dL
   1.1 mg/dL
   24 mEq/L
   4.1 mEq/L
   20 mg/dL
   107 mEq/L
   142 mEq/L
   41.6 %
   17.5 K/uL
        [image002.jpg]
                            [**2160-12-24**]  10:49 AM
                            [**2160-12-24**]  06:26 PM
                            [**2160-12-25**]  12:18 AM
                            [**2160-12-25**]  06:25 AM
                            [**2160-12-26**]  05:12 AM
   WBC
   17.1
   16.8
   17.5
   Hct
   37.9
   36.7
   41.6
   Plt
   [**Telephone/Fax (3) 3586**]56
   180
   Cr
   0.9
   1.1
   TropT
   10.95
   8.17
   6.80
   Glucose
   106
   97
   Other labs: PT / PTT / INR:12.8/27.2/1.1, CK / CKMB /
   Troponin-T:2195/128/6.80, Ca++:8.4 mg/dL, Mg++:2.1 mg/dL, PO4:2.5 mg/dL
   Assessment and Plan
   ASSESSMENT AND PLAN:  59 yo M with PMH of CAD s/p RCA stent in '[**48**]
   presenting with inferior STEMI, found to have in stent thrombosis and
   restenosis of prior RCA stent, now s/p stent to (prox) RCA.
   .
   #. CAD: EKG consistent with inferoposterolateral ischemia.  AM EKG with
   persistent ST elevations and Q waves in II, III, AVF, Cardiac cath
   notable RCA disease s/p drug-eluting stent, 40% stenosis in LAD and LCX
   as well as a myocardial bridge.  Risk factors for CAD include
   borderline hypertension and dyslipidemia, both formerly diet
   controlled. Most recent lipid panel notable for LDL of 123.  Patient
   HR and BPs have been improving.
   - Continue ASA, plavix, high dose statin, captopril.
   - start low dose metoprolol, uptitrate captopril today.
   - Morphine PRN for CP
   .
   #. Pump:  Patient with elevated JVP, c/w RV failure presentation.  Echo
   shows 40-45% EF.
   .
   #. Rhythm: NSR with HR on low side.
   - Monitor on tele
   .
   #. Hyperlipidemia:
   - start high dose statin
   .
   #. FEN: Cardiac diet. Follow and replete electrolytes.
   .
   #. Access: PIV
   .
   #. PPx: PO diet.  SC Heparin
   .
   #. Code: Full
   .
   #. Contact: Girlfriend for 26 years, [**First Name8 (NamePattern2) 787**] [**Last Name (NamePattern1) 3548**]
               H: [**Telephone/Fax (1) 3549**]
               C: [**Telephone/Fax (1) 3550**]
   .
   #. Dispo: CCU for now; will likely call out to [**Hospital Ward Name 289**] 3 if pt stable.
   1. IV access: Peripheral line, Date inserted: [**2160-12-24**] Order date:
   [**12-24**] @ 1019
   8. Heparin 5000 UNIT SC TID  Order date: [**12-24**] @ 1019
   2. Acetaminophen 325-650 mg PO Q6H:PRN  Order date: [**12-24**] @ 1019
   9. Influenza Virus Vaccine 0.5 mL IM ASDIR
   Follow Influenza Protocol Document administration in POE   Order date:
   [**12-24**] @ 1013
   3. Aspirin EC 325 mg PO DAILY  Order date: [**12-24**] @ 0934
   10. Morphine Sulfate 1-2 mg IV Q4H:PRN Pain
   Please hold for sedation or RR < 12.  Order date: [**12-24**] @ 1712
   4. Atorvastatin 80 mg PO DAILY  Order date: [**12-24**] @ 1019
   11. Senna 1 TAB PO BID:PRN  Order date: [**12-24**] @ 1019
   5. Captopril 3.125 mg PO TID
   Hold for SBP < 90  Order date: [**12-25**] @ 1326
   12. Sertraline 75 mg PO DAILY  Order date: [**12-25**] @ 1549
   6. Clopidogrel 75 mg PO DAILY
   for the recommended duration  Order date: [**12-24**] @ 0934
   13. Sodium Chloride 0.9% Flush 3 mL IV Q8H:PRN line flush
   Peripheral line: Flush with 3 mL Normal Saline every 8 hours and PRN.
   Order date: [**12-24**] @ 1019
   7. Docusate Sodium 100 mg PO BID  Order date: [**12-24**] @ 1019
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 EKG - At [**2160-12-25**] 08:00 AM
   Allergies:
   Sulfonamides
   Unknown;
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Morphine Sulfate - [**2160-12-25**] 09:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2160-12-26**] 06:35 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.3
C (100.9
   Tcurrent: 37.4
C (99.3
   HR: 70 (60 - 77) bpm
   BP: 106/70(79) {93/53(62) - 110/73(80)} mmHg
   RR: 22 (16 - 28) insp/min
   SpO2: 93%
   Heart rhythm: SR (Sinus Rhythm)
                  Total In:
                                                                  1,045 mL
                  PO:
                                                                    640 mL
                  TF:
   IVF:
                                                                    405 mL
   Blood products:
   Total out:
                                                                  1,375 mL
                                                                    550 mL
   Urine:
                                                                  1,375 mL
                                                                    350 mL
   NG:
   Stool:
   200 mL
   Drains:
   Balance:
                                                                   -330 mL
                                                                   -550 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 93%
   ABG: ///24/
   Physical Examination
   Gen: WDWN middle aged male in NAD. Oriented x3. Mood, affect
   appropriate.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   Neck: Supple with JVP of 8 cm.
   CV: PMI located in 5th intercostal space, midclavicular line. RR,
   normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4.
   Chest: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. CTAB, no crackles, wheezes or
   rhonchi.
   Abd: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by
   palpation. No abdominial bruits.
   Ext: No c/c/e. No femoral bruits on L. Femoral sheath in place on R
   Skin: No stasis dermatitis, ulcers, scars, or xanthomas.
   Labs / Radiology
   180 K/uL
   14.6 g/dL
   97 mg/dL
   1.1 mg/dL
   24 mEq/L
   4.1 mEq/L
   20 mg/dL
   107 mEq/L
   142 mEq/L
   41.6 %
   17.5 K/uL
        [image002.jpg]
                            [**2160-12-24**]  10:49 AM
                            [**2160-12-24**]  06:26 PM
                            [**2160-12-25**]  12:18 AM
                            [**2160-12-25**]  06:25 AM
                            [**2160-12-26**]  05:12 AM
   WBC
   17.1
   16.8
   17.5
   Hct
   37.9
   36.7
   41.6
   Plt
   [**Telephone/Fax (3) 3586**]56
   180
   Cr
   0.9
   1.1
   TropT
   10.95
   8.17
   6.80
   Glucose
   106
   97
   Other labs: PT / PTT / INR:12.8/27.2/1.1, CK / CKMB /
   Troponin-T:2195/128/6.80, Ca++:8.4 mg/dL, Mg++:2.1 mg/dL, PO4:2.5 mg/dL
   Assessment and Plan
   ASSESSMENT AND PLAN:  59 yo M with PMH of CAD s/p RCA stent in '[**48**]
   presenting with inferior STEMI, found to have in stent thrombosis and
   restenosis of prior RCA stent, now s/p stent to (prox) RCA.
   .
   #. CAD: EKG consistent with inferoposterolateral ischemia.  AM EKG with
   persistent ST elevations and Q waves in II, III, AVF, Cardiac cath
   notable RCA disease s/p drug-eluting stent, 40% stenosis in LAD and LCX
   as well as a myocardial bridge.  Risk factors for CAD include
   borderline hypertension and dyslipidemia, both formerly diet
   controlled. Most recent lipid panel notable for LDL of 123.  Patient
   HR and BPs have been improving.
   - Continue ASA, plavix, high dose statin, captopril.
   - start low dose metoprolol, uptitrate captopril today.
   - Morphine PRN for CP
   .
   #. Pump:  Patient with elevated JVP, c/w RV failure presentation.  Echo
   shows 40-45% EF.
   .
   #. Rhythm: NSR with HR on low side.
   - Monitor on tele
   .
   #. Hyperlipidemia:
   - start high dose statin
   .
   #. FEN: Cardiac diet. Follow and replete electrolytes.
   .
   #. Access: PIV
   .
   #. PPx: PO diet.  SC Heparin
   .
   #. Code: Full
   .
   #. Contact: Girlfriend for 26 years, [**First Name8 (NamePattern2) 787**] [**Last Name (NamePattern1) 3548**]
               H: [**Telephone/Fax (1) 3549**]
               C: [**Telephone/Fax (1) 3550**]
   .
   #. Dispo: CCU for now; will likely call out to [**Hospital Ward Name 289**] 3 if pt stable.
   1. IV access: Peripheral line, Date inserted: [**2160-12-24**] Order date:
   [**12-24**] @ 1019
   8. Heparin 5000 UNIT SC TID  Order date: [**12-24**] @ 1019
   2. Acetaminophen 325-650 mg PO Q6H:PRN  Order date: [**12-24**] @ 1019
   9. Influenza Virus Vaccine 0.5 mL IM ASDIR
   Follow Influenza Protocol Document administration in POE   Order date:
   [**12-24**] @ 1013
   3. Aspirin EC 325 mg PO DAILY  Order date: [**12-24**] @ 0934
   10. Morphine Sulfate 1-2 mg IV Q4H:PRN Pain
   Please hold for sedation or RR < 12.  Order date: [**12-24**] @ 1712
   4. Atorvastatin 80 mg PO DAILY  Order date: [**12-24**] @ 1019
   11. Senna 1 TAB PO BID:PRN  Order date: [**12-24**] @ 1019
   5. Captopril 3.125 mg PO TID
   Hold for SBP < 90  Order date: [**12-25**] @ 1326
   12. Sertraline 75 mg PO DAILY  Order date: [**12-25**] @ 1549
   6. Clopidogrel 75 mg PO DAILY
   for the recommended duration  Order date: [**12-24**] @ 0934
   13. Sodium Chloride 0.9% Flush 3 mL IV Q8H:PRN line flush
   Peripheral line: Flush with 3 mL Normal Saline every 8 hours and PRN.
   Order date: [**12-24**] @ 1019
   7. Docusate Sodium 100 mg PO BID  Order date: [**12-24**] @ 1019<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 59-year-old male with a history of coronary artery disease (CAD) who presented with inferior ST-elevation myocardial infarction (STEMI) and was found to have in-stent thrombosis and restenosis of his prior right coronary artery (RCA) stent. He underwent stenting of the proximal RCA and is currently admitted to the intensive care unit (ICU).

The patient's vital signs are stable, with a temperature of 37.4°C (99.3°F), heart rate of 70 beats per minute (bpm), and blood pressure of 106/70 mmHg. His respiratory rate is 22 inspirations per minute, and his oxygen saturation is 93% on room air.

The patient's physical examination is notable for a supple neck with a jugular venous pressure (JVP) of 8 cm, and cardiac examination reveals a normal sinus rhythm (NSR) with a heart rate on the low side. His lung fields are clear, and his abdomen is soft and non-tender.

The patient's laboratory results show elevated troponin levels, with a peak value of 10.95 ng/mL, and a cardiac troponin I level of 6.80 ng/mL. His creatine kinase (CK) and CK-MB levels are elevated, with a peak CK level of 2195 U/L and a peak CK-MB level of 128 U/L. His lactate dehydrogenase (LDH) level is elevated, with a peak value of 107 mg/dL.

The patient's medical history is significant for CAD, hypertension, and dyslipidemia. He is currently taking aspirin, clopidogrel, atorvastatin, captopril, and metoprolol.

Potential medical complications that can arise from the patient's condition include:

1. Cardiac arrhythmias: The patient's history of CAD and his current condition may increase his risk of developing cardiac arrhythmias, such as atrial fibrillation or ventricular tachycardia.
2. Heart failure: The patient's elevated JVP and decreased ejection fraction (EF) suggest that he may be at risk for developing heart failure.
3. Myocardial infarction: The patient's elevated troponin levels and cardiac troponin I level suggest that he may have had a recent myocardial infarction.
4. Cardiac rupture: The patient's elevated troponin levels and cardiac troponin I level suggest that he may be at risk for developing cardiac rupture.
5. Infection: The patient's history of CAD and his current condition may increase his risk of developing an infection, such as sepsis or pneumonia.
6. Renal failure: The patient's elevated creatinine level and decreased ejection fraction (EF) suggest that he may be at risk for developing renal failure.
7. Respiratory failure: The patient's history of CAD and his current condition may increase his risk of developing respiratory failure, such as chronic obstructive pulmonary disease (COPD) or pneumonia.

Based on the patient's condition and medical history, it is recommended that he continue to receive close monitoring and treatment in the ICU."
